Overexpression of Sprouty 2 in mouse lung epithelium inhibits urethane-induced tumorigenesis

American Journal of Respiratory Cell and Molecular Biology

Volumn 40, Issue 1, 2009, Pages 31-37

  Minowada, George ^a   Miller, York E ^b,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chemoprevention; Lung cancer; Mouse; Ras; Sprouty

Indexed keywords

INHIBITOR PROTEIN; SPROUTY 2; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; URETHAN; CARCINOGEN; CARCINOPLACENTAL ISOENZYMES; ISOENZYME; KRAS2 PROTEIN, MOUSE; MEMBRANE PROTEIN; PROTEIN P21; SPRY2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; GENE MUTATION; LUNG ALVEOLUS EPITHELIUM; LUNG CARCINOGENESIS; LUNG TUMOR; MOUSE; MUTATION RATE; NONHUMAN; ONCOGENE K RAS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR VOLUME; ANIMAL; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; RESPIRATORY TRACT MUCOSA; TRANSGENIC MOUSE;

MUS; NICOTIANA TABACUM;

ANIMALS; CARCINOGENS; FEMALE; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS P21(RAS); RESPIRATORY MUCOSA; URETHANE;

EID: 58149359604     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0147OC     Document Type: Article

References (31)

1. Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol 2002;64:681-708.
2. Sato M, Shames DS, Gazdar AF, Minna JD. A translational view of the molecular pathogenesis of lung cancer. J horac Oncol 2007;2:327-343.
3. Khosravi-Far R, Der CJ. The Ras signal transduction pathway. Cancer Metastasis Rev 1994;13:67-89.
4. Malkinson AM. Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung. Lung Cancer 2001;32:265-279.
5. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA, Jacks T. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001;410:1111-1116.
6. Fisher GH, Wellen SL, Klimstra D, Lenczowski JM, Tichelaar JW, Lizak MJ, Whitsett JA, Koretsky A, Varmus HE. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev 2001;15:3249-3262.
7. Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA. sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 1998;92:253-263.
8. Casci T, Vinos J, Freeman M. Sprouty, an intracellular inhibitor of Ras signaling. Cell 1999;96:655-665.
9. Minowada G, Jarvis LA, Chi CL, Neubuser A, Sun X, Hacohen N, Krasnow MA, Martin GR. Vertebrate Sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed. Development 1999;126:4465-4475.
10. Cabrita MA, Christofori G. Sprouty proteins: antagonists of endothelial cell signaling and more. Thromb Haemost 2003;90:586-590.
11. Lee CC, Putnam AJ, Miranti CK, Gustafson M, Wang LM, Vande Woude GF, Gao CF. Overexpression of sprouty 2 inhibits HGF/SF- mediated cell growth, invasion, migration, and cytokinesis. Oncogene 2004;23:5193-5202.
12. Kim HJ, Bar-Sagi D. Modulation of signalling by Sprouty: a developing story. Nat Rev Mol Cell Biol 2004;5:441-450.
13. Guy GR, Wong ES, Yusoff P, Chandramouli S, Lo TL, Lim J, Fong CW. Sprouty: how does the branch manager work? J Cell Sci 2003;116:3061-3068.
14. Christofori G. Split personalities: the agonistic antagonist Sprouty. Nat Cell Biol 2003;5:377-379.
15. Mailleux AA, Tefft D, Ndiaye D, Itoh N, Thiery JP, Warburton D, Bellusci S. Evidence that SPROUTY2 functions as an inhibitor of mouse embryonic lung growth and morphogenesis. Mech Dev 2001;102:81-94.
16. Sutterluty H, Mayer CE, Setinek U, Attems J, Ovtcharov S, Mikula M, Mikulits W, Micksche M, BergerW. Down-regulationofSprouty2innon-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms. Mol Cancer Res 2007;5:509-520.
17. Shaw AT, Meissner A, Dowdle JA, Crowley D, Magendantz M, Ouyang C, Parisi T, Rajagopal J, Blank LJ, Bronson RT, et al. Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis. Genes Dev 2007;21:694-707.
18. Lobe CG, Koop KE, Kreppner W, Lomeli H, Gertsenstein M, Nagy A. Z/AP, a double reporter for cre-mediated recombination. Dev Biol 1999;208:281-292.
19. Perl AK, Tichelaar JW, Whitsett JA. Conditional gene expression in the respiratory epithelium of the mouse. Transgenic Res 2002;11:21-29.
20. Tichelaar JW, Lu W, Whitsett JA. Conditional expression of fibroblast growth factor-7 in the developing and mature lung. J Biol Chem 2000;275:11858-11864.
21. Nuzum EO, Malkinson AM, Beer DG. Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas. Mol Carcinog 1990;3:287-295.
22. Shimkin MB, Polissar MJ. Some quantitative observations on the induction and growth of primary pulmonary tumors in strain A mice receiving urethan. J Natl Cancer Inst 1955;16:75-97.
23. Dyson P, Heppleston AG. Cell kinetics of urethane induced murine pulmonary adenomata: I. The growth rate. Br JCancer 1975;31:405-416.
24. Lamerton LF, Steel GG. Cell population kinetics in normal and malignant tissues. Prog Biophys Mol Biol 1968;18:245-283.
25. Gunning WT, Kramer PM, Lubet RA, Steele VE, Pereira MA. Chemo-prevention of vinyl carbamate-induced lung tumors in strain A mice.Exp Lung Res 2000;26:757-772.
26. Gunning WT, Kramer PM, Steele VE, Pereira MA. Chemoprevention by lipoxygenase and leukotriene pathway inhibitors of vinyl carbamate-induced lung tumors in mice. Cancer Res 2002;62:4199-4201.
27. Moody TW, Leyton J, Zakowicz H, Hida T, Kang Y, Jakowlew S, You L, Ozbun L, Zia H, Youngberg J, et al. Indomethacin reduces lung adenoma number in A/J mice. Anticancer Res 2001;21:1749-1755.
28. JalbertG, CastonguayA. EffectsofNSAIDsonNNK-inducedpulmonary and gastric tumorigenesis in A/J mice. Cancer Lett 1992;66:21-28.
29. Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G, Ittmann M. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res 2004;64:4728-4735.
30. Lo TL, Yusoff P, Fong CW, Guo K, McCaw BJ, Phillips WA, Yang H, Wong ES, Leong HF, Zeng Q, et al. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Res 2004;64:6127-6136.
31. Minowada G, Miller YE. Sprouty 2 gene in mouse lung tumorigenesis. Chest 2004;125:111S.